Intended for healthcare professionals

Letters Prostate cancer screening

Study has major shortcomings

BMJ 2011; 342 doi: (Published 14 June 2011) Cite this as: BMJ 2011;342:d3704
  1. Fritz H Schroder, urologist1
  1. 1Erasmus Medical Centre, Rotterdam, Netherlands
  1. secr.schroder{at}

Although Sandblom and colleagues’ study is the longest follow-up to date of prostate cancer screening,1 it has some major shortcomings.

  • (1) The group of men randomised to screening is small. Of the 1494 men, only 1161 participated in the initial screening (78%). Those who refused are apparently …

View Full Text

Log in

Log in through your institution


* For online subscription